Αποτελέσματα Αναζήτησης
Depression among hospitalized patients is often unrecog-nized, undiagnosed, and therefore untreated. Little is known about the feasibility of screening for depression during hos-pitalization, or whether depression is associated with poor-er outcomes, longer hospital stays, and higher readmission rates.
1 Φεβ 2003 · The HADS-D and HADS-A were found to be reliable tools for detecting depression and anxiety, respectively, in hospital clinics and effective indices to measure the severity of mood disorders.
1 Φεβ 2017 · The efficacy of hospitalization screening for depression is unclear, or whether depression is associated with worse outcomes, longer hospital stays as well as higher readmission rates. ...
The Hospital Anxiety and Depression Scale (HADS) is a 14-item tool used to screen for anxiety and depression, which commonly coexist. The HADS produces a subscale for anxiety (HADS-A) and a separate subscale for depression (HADS-D). The HADS can be administered in 5 minutes.
This report will be used by the U.S. Preventive Services Task Force (USPSTF) to update its 2016 recommendation for Screening for Depression in Adults and its 2013 Screening for Suicide Risk in Primary Care, and to develop a new recommendation on screening for anxiety disorders.
The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression: The PHQ-9 incorporates DSM-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self-report tool.
10 Μαΐ 2021 · Objective: To evaluate the accuracy of the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) to screen for major depression among people with physical health problems. Design: Systematic review and individual participant data meta-analysis.
